A study highlights the rise of hybrid prenatal care during the COVID-19 public health emergency, though telehealth's potential remains underutilized across racial and geographic groups.
Hybrid prenatal care use significantly rose during the COVID-19 public health emergency (PHE), according to a recent study published in JAMA Network Open.1
The odds of not receiving prenatal care are 3.5% in non-Hispanic Black patients and 2.7% in Hispanic patients, highlighting an increased risk compared to non-Hispanic White patients at 1.4%. Telehealth has been endorsed by multiple federal agencies for use in some aspects of prenatal care, potentially eliminating barriers to care.
The Centers for Medicare and Medicaid Services allowed physicians for telehealth services to receive reimbursement during the COVID-19 PHE.2 However, data about the use of telehealth services among racial and ethnic groups remains unclear.1
To evaluate telehealth and in-person prenatal care before and during the COVID-19 PHE, investigators conducted a retrospective cohort study. Data was obtained from the National COVID Cohort Collaborative (N3C) Data Enclave.
The N3C includes hospital visit records and EHR data for patients with and without COVID-19 starting January 2017. There were 349,682 childbirths included in the cohort through May 31, 2022.
Gestational week during childbirth was reported, then converted into days and subtracted from the childbirth date to determine the pregnancy conception date. Prenatal care data was assessed from prenatal care initiation to childbirth delivery date.
This data was used to identify care at in-person visits vs telehealth visits. Hybrid care was defined as having at least 1 of each visit type.
Eligible patients included pregnant individuals aged 15 to 49 years with delivery occurring between June 1, 2018, and May 31, 2022. No participant received exclusively telehealth care, with hybrid prenatal care reported as the primary outcome.
Modalities of telehealth included interactive video or audio communication, texting, digital evaluation and management services, asynchronous telecommunication platforms, and other telehealth concepts. COVID-19 PHE was defined as an exposure, alongside urban vs rural status and race and ethnicity.
Participants were aged a mean 29.4 years, and 4.2% of pregnancies were in Asian patients, 18.8% Black, 17.1% Hispanic, 46.5% White, and 13.4% non-Hispanic individuals of another race. No prepregnancy overweight or obesity was reported in 69.3% of patients, a singleton birth in 95.1%, and vaginal delivery in 88.7%.
A median 14 visits were reported in the study sample. This included a median 13 in-person visits in the overall population and a median 2 telehealth visits among telehealth users. Prenatal PHE exposure was linked to a slight reduction in the number of prenatal care visits over time, from a median 15 visits without PHE exposure to 13 with prenatal PHE exposure.
An increase in telehealth visits was also reported alongside the decrease in overall visits, from an average of 0.4% to 2.2% in the total study population. Telehealth visits comprised a mean under 1% of visits in pregnancies without PHE exposure, vs 1.9% in the partially overlapping group and 2.2% in the fully overlapping group.
Prenatal care initiation occurred most often at 8- to 10-weeks’ gestation overall, vs 9- to 13-weeks’ gestation for initial telehealth visits. Hybrid prenatal care steadily rose between March and July of 2020, and the peak of 8.1% was observed in November 2020.
In the full PHE exposure cohort, the highest rates of hybrid prenatal care use were observed among Asian and Black individuals, at 11.5% and 10.3%, respectively. Hispanic patients also had an increased rate compared to White patients, at 10% vs 8.3%, respectively. Urban residents had higher rates than rural residents, but both groups experienced increases from PHE exposure.
These results indicated an increase in prenatal telehealth care during the COVID-19 PHE. However, telehealth use remained low, indicating the benefits of telehealth expansion have not been fully realized.
References
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Study shows a healthy prenatal diet could be upstream obesity prevention strategy
December 26th 2024"Our findings support the recommendation of a healthy diet based on the current guidelines (as measured by the HEI) during pregnancy, since it may reduce patterns of infant growth outside reference ranges."
Read More